Karen Lewis - 28 Jan 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief People Officer
Signature
/s/ David Watson, Attorney-in-fact for Karen Lewis
Issuer symbol
APLS
Transactions as of
28 Jan 2022
Net transactions value
-$16,748
Form type
4
Filing time
01 Feb 2022, 16:59:10 UTC
Previous filing
25 Jan 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $16,748 -434 -1.8% $38.59 23,474 28 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.